Merck Acquires Bio-Techne, Expanding Biotech Presence

Bio-Techne shareholders have approved the company's acquisition by Merck KGaA. This move marks a significant development in the biotech sector, with Bio-Techne being a leading player in the industry.

The acquisition is expected to strengthen Merck's position in the market and expand its offerings in the biotechnology space. Details of the deal have not been disclosed, but it is likely that the acquisition will provide a boost to Merck's research and development capabilities.